Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (1.020)

1

Letter to the editor : Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Kow, C. | Ramachandram, D. | Hasan, S. | +1

2

Author's response : Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Klitting, R. | de Lamballerie, X. | all co-authors of the original article

3

Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies

enthalten in: Signal transduction and targeted therapy | 2024

von Wang, X. | Jiang, S. | Ma, W. | +2

4

Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients

enthalten in: Inflammatory bowel diseases | 2024

von González Cueto, E. | Edmans, M. | Wellens, J. | +13

5

Neutralizing antibody levels and cellular immune response against Omicron variant in pregnant women vaccinated with mRNA and inactivated SARS-CoV-2 vaccines

enthalten in: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology | 2024

von Kalafat, E. | Talay, Z. | Demirci, O. | +17

6

Immunogenicity of BNT162b2 vaccine after two and three doses : Correspondence

enthalten in: Semergen | 2024

von Daungsupawong, H. | Wiwanitkit, V.

7

Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis : analysis of a prospective cohort

enthalten in: Clinical and experimental rheumatology | 2024

von Bartoletti, A. | Fornara, C. | Delvino, P. | +5

8

Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis : a cohort study

enthalten in: Annals of the rheumatic diseases | 2024

von Schiff, A. | Wang, X. | Patel, N. | +13

UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462

9

The continuous surprises that SARS-CoV-2 presents to the scientific community - Correspondence about the Paper Fusco G, Cardillo L, Levante M, Brandi S, Picazio G, Napoletano M, Martucciello A, Fiorito F, De Carlo E, De Martinis C. First serological evidence of SARS-CoV-2 natural infection in small ruminants : brief report. Vet Res Commun. 2023 sep;47(3):1741-1748. Doi: 10.1007/s11259-022-10044-3

enthalten in: Veterinary research communications | 2024

von Teixeira, A.

10

Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination

enthalten in: The Journal of infection | 2024

von Sun, L. | Man, Q. | Zhang, H. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[102]